Literature DB >> 25748638

Detection of replication competent adenovirus upon serial passaging of recombinant adenovirus expressing FMDV capsid proteins.

Ramesh Kumar1, Suresh H Basagoudanavar1, B P Sreenivasa2.   

Abstract

Replication deficient human adenovirus type 5 (hAd5) is an important gene delivery vehicle and has been used in various fields of biomedical sciences such as gene therapy, cancer therapy and vaccination. Inspite of its various useful features, emergence of replication competent adenovirus (RCA) in recombinant virus stocks is a great concern. In the present study, recombinant adenovirus expressing foot-and-mouth disease virus serotype-O capsid proteins was propagated in HEK-293 cells and purified by CsCl density gradient ultracentrifugation. The virus was serially passaged in HEK-293 cells and at passage level (P) 2-4, 6, 8 and 12, tested for the presence of RCA. A vector dose of 2 × 10(8) and 1 × 10(10) TCID50 of the virus was used in cell line bioassay and PCR, respectively. Our results demonstrated that the PCR is more sensitive and rapid technique for the detection of RCA in recombinant adenovirus stocks as early as at P3, whereas the bioassay detected the RCA at P8.
Copyright © 2015 The International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell line bioassay; FMD virus; HEK-293; Human adenovirus type 5; PCR; Replication competent adenovirus

Mesh:

Substances:

Year:  2015        PMID: 25748638     DOI: 10.1016/j.biologicals.2015.02.002

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  2 in total

1.  Generation of Replication Deficient Human Adenovirus 5 (Ad5) Vectored FMD Vaccines.

Authors:  Gisselle N Medina; Teresa de Los Santos; Fayna Díaz-San Segundo
Journal:  Methods Mol Biol       Date:  2022

2.  Adenovirus-Vectored Capsid Proteins of the Serotype A Foot-and-Mouth Disease Virus Protect Guinea Pigs Against Challenge.

Authors:  Yinli Xie; Huiyun Chang; Zhiyong Li; Yanming Zhang
Journal:  Front Microbiol       Date:  2020-07-09       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.